117 related articles for article (PubMed ID: 6897203)
41. Diffuse small noncleaved-cell, non-Burkitt's lymphoma in adults: a high-grade lymphoma responsive to ProMACE-based combination chemotherapy.
Longo DL; Duffey PL; Jaffe ES; Raffeld M; Hubbard SM; Fisher RI; Wittes RE; DeVita VT; Young RC
J Clin Oncol; 1994 Oct; 12(10):2153-9. PubMed ID: 7523607
[TBL] [Abstract][Full Text] [Related]
42. Aggressive chemotherapy in the treatment of Burkitt's and non-Burkitt's undifferentiated lymphoma.
Mazza JJ; Hines JD; Andersen JW; Neiman RS; Mann R; Oken MM; O'Connell MJ
Leuk Lymphoma; 1995 Jul; 18(3-4):289-96. PubMed ID: 8535195
[TBL] [Abstract][Full Text] [Related]
43. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol].
Mihaljević B; Jancić-Nedeljkov R; Sretenović M; Milivojević G; Janković S; Petrović M
Srp Arh Celok Lek; 1998; 126(9-10):345-8. PubMed ID: 9863405
[TBL] [Abstract][Full Text] [Related]
44. A pilot study on the use of the ProMACE-CytaBOM regimen as a first-line treatment of advanced follicular non-Hodgkin's lymphoma. Gruppo Italiano per lo Studio dei Linfomi.
Baldini L; Guffanti A; Gobbi P; Colombi M; Federico M; Avanzini P; Cavanna L; Pieresca C; Silingardi V; Maiolo AT
Cancer; 1997 Mar; 79(6):1234-40. PubMed ID: 9070503
[TBL] [Abstract][Full Text] [Related]
45. Combination chemotherapy with cyclophosphamide, vincristine, prednisone and the contribution of adriamycin in the treatment of adult non-Hodgkin's lymphomas a report of 131 cases.
Parlier Y; Gorin NC; Najman A; Stachowiak J; Duhamel G
Cancer; 1982 Aug; 50(3):401-9. PubMed ID: 7046899
[TBL] [Abstract][Full Text] [Related]
46. [Clinical characteristics and treatment outcome of 36 cases with non-Hodgkin's lymphoma arising from mediastinum in children].
Tang YJ; Tang JY; Pan C; Xue HL; Chen J; Shen SH; Dong L; Zhou M; Wang YP; Gu LJ; Jiang H; Ye QD
Zhonghua Er Ke Za Zhi; 2009 Sep; 47(9):687-90. PubMed ID: 20021793
[TBL] [Abstract][Full Text] [Related]
47. [Treatment results and prognostic significance of selected clinical and laboratory features in children diagnosed with malignant lymphoma].
Kamieńska E
Ann Acad Med Stetin; 1996; 42():105-22. PubMed ID: 9199116
[TBL] [Abstract][Full Text] [Related]
48. [Prognostic changes in juvenile abdominal non-Hodgkin's lympomas (NHL)].
Sigg C; Plüss HJ; Hitzig WH
Schweiz Med Wochenschr; 1980 Jul; 110(27-28):1056-9. PubMed ID: 7423149
[TBL] [Abstract][Full Text] [Related]
49. [Non-Hodgkin's lymphomas in childhood. Evaluation of therapeutic results according to histopathologic criteria (Catalan Interhospital Group of Pediatric Oncology)].
Cubells Riero J; Pardo García N; Turmo Martí J; Vela Ferrer E; Badía Torroella RM; González Rivero MA; Illa Sala J; Melo Valls M
An Esp Pediatr; 1988 Sep; 29(3):203-7. PubMed ID: 3195869
[TBL] [Abstract][Full Text] [Related]
50. 5-year survey of methotrexate, cyclophosphamide (Endoxan), and vincristine (MEV) therapy for advanced non-Hodgkin's lymphomas.
Lauria F; Baccarani M; Fiacchini M; Frezza R; Gobbi M; Tura S
Cancer Treat Rep; 1978 Aug; 62(8):1193-7. PubMed ID: 688255
[TBL] [Abstract][Full Text] [Related]
51. Studies on the pathology of non-Hodgkin's lymphoma of childhood. I. The role of routine histopathology as a prognostic factor. A report from the Children's Cancer Study Group.
Wilson JF; Jenkin RD; Anderson JR; Chilcote RR; Coccia P; Exelby PR; Kersey J; Kjeldsberg CR; Kushner J; Meadows A
Cancer; 1984 Apr; 53(8):1695-704. PubMed ID: 6697306
[TBL] [Abstract][Full Text] [Related]
52. The long-term outlook for children treated for non-Hodgkin lymphomas. A report of the Children's Solid Tumour Group.
Goldman A
Br J Cancer; 1981 Dec; 44(6):872-8. PubMed ID: 7326196
[TBL] [Abstract][Full Text] [Related]
53. CODOX-M/IVAC (NCI 89-C-41) in children and adolescents with Burkitt's leukemia/lymphoma and large B-cell lymphomas: a 15-year monocentric experience.
Moleti ML; Testi AM; Giona F; Malandruccolo L; Pescarmona E; Martino P; Paoloni F; Barberi W; Palumbo G; Mandelli F; Foa R
Leuk Lymphoma; 2007 Mar; 48(3):551-9. PubMed ID: 17454598
[TBL] [Abstract][Full Text] [Related]
54. Long-term results of the AIEOP LNH-97 protocol for childhood lymphoblastic lymphoma.
Pillon M; Aricò M; Mussolin L; Carraro E; Conter V; Sala A; Buffardi S; Garaventa A; D'Angelo P; Lo Nigro L; Santoro N; Piglione M; Lombardi A; Porta F; Cesaro S; Moleti ML; Casale F; Mura R; d'Amore ES; Basso G; Rosolen A
Pediatr Blood Cancer; 2015 Aug; 62(8):1388-94. PubMed ID: 25755200
[TBL] [Abstract][Full Text] [Related]
55. HiC-COM: a 2-month intensive chemotherapy regimen for children with stage III and IV Burkitt's lymphoma and B-cell acute lymphoblastic leukemia.
Schwenn MR; Blattner SR; Lynch E; Weinstein HJ
J Clin Oncol; 1991 Jan; 9(1):133-8. PubMed ID: 1985162
[TBL] [Abstract][Full Text] [Related]
56. Combination chemotherapy followed by an immunotoxin (anti-B4-blocked ricin) in patients with indolent lymphoma: results of a phase II study.
Longo DL; Duffey PL; Gribben JG; Jaffe ES; Curti BD; Gause BL; Janik JE; Braman VM; Esseltine D; Wilson WH; Kaufman D; Wittes RE; Nadler LM; Urba WJ
Cancer J; 2000; 6(3):146-50. PubMed ID: 10882329
[TBL] [Abstract][Full Text] [Related]
57. Non-Hodgkin's lymphoma in children.
Pinkel D; Johnson W; Aur RJ
Br J Cancer Suppl; 1975 Mar; 2():298-323. PubMed ID: 1101924
[TBL] [Abstract][Full Text] [Related]
58. Combined cyclophosphamide vincristine, procarbazine, and prednisone (COPP) therapy of malignant lymphoma. Evaluation of 190 patients.
Morgenfeld MC; Pavlovsky A; Suarez A; Somoza N; Pavlovsky S; Palau M; Barros CA
Cancer; 1975 Oct; 36(4):1241-9. PubMed ID: 1100220
[TBL] [Abstract][Full Text] [Related]
59. Methotrexate as a single agent and in combination chemotherapy for the treatment of non-Hodgkin's lymphoma of unfavorable histology.
Canellos GP; Skarin AT; Rosenthal DS; Moloney WC; Frei E
Cancer Treat Rep; 1981; 65 Suppl 1():125-9. PubMed ID: 6173118
[TBL] [Abstract][Full Text] [Related]
60. [Adriamycin for the treatment of non HOdgkin's lymphomas (author's transl)].
Parlier Y; Gorin NC; Stachowiak J; Najman A; Duhamel G
Sem Hop; 1981 Nov 8-25; 57(41-42):1685-90. PubMed ID: 6272402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]